Joris Delanghe

Title: Innovations of Joris Delanghe: Pioneering Treatments for Ocular Diseases

Introduction: Joris Delanghe, an esteemed inventor based in Aalst, Belgium, has made significant contributions to the field of ocular health. With three patents to his name, his innovative approaches address major vision impairments such as age-related presbyopia, age-related macular degeneration (AMD), and diabetic complications affecting the eyes. His work reflects a strong commitment to addressing unmet medical needs in vision science.

Latest Patents: Delanghe's latest patents include groundbreaking treatments aimed at combating advanced glycation end products (AGEs) in ocular diseases. One prominent patent focuses on "Compositions for use to treat advanced glycation end products-dependent ocular diseases." This innovative treatment is particularly relevant for conditions such as age-related presbyopia, where individuals over 40-50 years experience a decline in vision that standard reading glasses do not rectify. AMD, the leading cause of irreversible vision loss in individuals over 65, also falls under his purview, particularly its dry form, which remains without an effective treatment. Furthermore, he addresses diabetic retinopathy and diabetic macular edema, the most common causes of vision impairment in those under 65. Delanghe's research emphasizes the administration of fructosamine-3-kinase and its cofactor(s) to facilitate deglycation and inactivation of harmful AGEs and fluorophores.

Another notable patent involves the "Direct infrared analysis of post-translational modification of proteins." This method involves measuring the infrared radiation attenuated by the skin of a subject, thus providing valuable insights into protein modifications without needing to detach the integument from the subject.

Career Highlights: Throughout his career, Joris Delanghe has been associated with prestigious entities such as Ghent University and VIB (Flanders Institute for Biotechnology). His background in science and research has fostered an environment conducive to pioneering advancements in health care.

Collaborations: In his professional journey, Delanghe has collaborated with notable individuals like Elisabeth Van Aken and Marijn Speeckaert. Together, they have explored innovative solutions to complex medical issues, significantly enhancing the impact of their research.

Conclusion: Joris Delanghe stands out as a dedicated inventor whose work has the potential to transform treatment methodologies for ocular diseases. His innovative patents not only showcase his expertise but also reflect a profound understanding of the pressing challenges in vision science. Through his contributions, Delanghe continues to pave the way for advancements that aim to improve the quality of life for countless individuals affected by vision impairment.